Literature DB >> 19562645

The importance of drug-target residence time.

Rumin Zhang1, Frederick Monsma.   

Abstract

The importance of kinetics in drug-target interactions, and particularly the residence time of a drug with its target, is increasingly recognized to play a pivotal role in determining both the efficacy and toxicity of a drug. Drug residence time can often be demonstrated to be a key differentiating factor between drugs that act upon a common target. Drug-target residence time can result in either favorable or unfavorable outcomes, and the use of such information could lead to the more efficient design of best-in-class drugs. This review highlights several key concepts and observations related to drug-target residence time, and suggests the use of a kinetics-perceptive and energetics-informed approach to address the challenges facing current drug discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562645

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  37 in total

1.  Functional efficacy of adenosine A₂A receptor agonists is positively correlated to their receptor residence time.

Authors:  Dong Guo; Thea Mulder-Krieger; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 2.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

Review 4.  The drug-target residence time model: a 10-year retrospective.

Authors:  Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

Review 5.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

6.  Discrimination between conformational selection and induced fit protein-ligand binding using Integrated Global Fit analysis.

Authors:  Franz-Josef Meyer-Almes
Journal:  Eur Biophys J       Date:  2015-11-04       Impact factor: 1.733

7.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

8.  Drug-target interactions: Stay tuned.

Authors:  Robert A Copeland
Journal:  Nat Chem Biol       Date:  2015-05-25       Impact factor: 15.040

9.  On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study.

Authors:  Karim M ElSawy; Chandra S Verma; Thomas L Joseph; David P Lane; Reidun Twarock; Leo S D Caves
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

10.  SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism.

Authors:  Laura M van Marrewijk; Steven W Polyak; Marcel Hijnen; Dana Kuruvilla; Mi Ra Chang; Youseung Shin; Theodore M Kamenecka; Patrick R Griffin; John B Bruning
Journal:  ACS Chem Biol       Date:  2015-12-03       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.